Bernd Bonnekoh
Papers
4
Total Citations
556
H-Index
4
About
Bernd Bonnekoh is a dermatological researcher whose work sits at the intersection of proteomics, immunology, and skin disease, with a particular focus on psoriasis pathology and treatment. He is best known for his pioneering contributions to automated multidimensional fluorescence microscopy and the application of Multi-Epitope Ligand Cartography (MELC) robot technology — methodologies that enable detailed topological and functional analysis of proteins within complex tissue environments. His 2006 paper on proteome topology and function using automated multidimensional fluorescence microscopy has garnered an impressive 495 citations, underscoring its foundational influence in the field of spatial proteomics. Bonnekoh has applied these innovative imaging tools to clinically relevant questions, notably investigating the molecular effects of efalizumab — a CD11a-targeting monoclonal antibody — in psoriatic plaque tissue and peripheral blood lymphocyte populations. His clinical pilot studies demonstrated meaningful treatment responses in psoriasis patients, with substantial reductions in PASI scores, while simultaneously elucidating the drug's binding mechanisms at the tissue level. Collectively, his research has helped bridge advanced proteomic imaging with translational dermatology, offering new frameworks for understanding immune-mediated skin conditions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4